Associate Director of Complex Coronary Interventions
Emory Heart and Vascular
Atlanta, Georgia, United States
Dr Stéphane Rinfret is an academic interventional cardiologist and world-renowned expert in CTO PCI. After a 20-carreer in Canada, he was recruited by Emory Heart and Vascular and appointed professor of Medicine at Emory University in 2021. He has published over 160 peer-reviewed articles and has been invited over 300 times to give lectures in the past 10 years. He is a high-volume coronary operator, with procedures performed predominantly in high-risk patients turned down for CABG or with a complex post CABG coronary anatomy. He is the founder and co-director of the Multi-Level CTO course, the largest CTO-dedicated course in Europe, and Editor of Percutaneous Coronary Intervention for Chronic Total Occlusion; the Hybrid Approach, 2nd Edition published by Springer Nature. Dr Rinfret serves as faculty in several cardiology meetings, and pursues very active clinical, research, proctoring and teaching career.
Saturday, February 25, 2023
8:00 AM – 10:02 AM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)
Saturday, February 25, 2023
8:00 AM – 8:50 AM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)
Saturday, February 25, 2023
10:02 AM – 10:10 AM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)
Saturday, February 25, 2023
10:58 AM – 11:18 AM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
5:00 PM – 6:00 PM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)
Sunday, February 26, 2023
5:45 PM – 6:00 PM ET
Disclosure(s): 4C Medical Technologies, Inc.: Stockholder/Ownership Interest (excluding diversified mutual funds) (Ongoing); BSCI: Honoraria (Ongoing); Medtronic Inc: Honoraria (Ongoing); Teleflex Inc: Consultant/Advisory Board (Ongoing)